Takeda Announces New Assignments of Directors

June 28, 2018

Osaka, Japan, June 28, 2018 – Takeda Pharmaceutical Company Limited (TSE 4502) today announced new assignment of Directors. The details are as follows;

 

1. New assignment of Non-Audit and Supervisory Committee Directors effective June 28, 2018

Name

Category

Current Role

Christophe Weber

Internal

Existing

Representative Director,

President & Chief Executive Officer

Masato Iwasaki

Internal

Existing

Director, President, Japan Pharma Business Unit

Andrew Plump

Internal

Existing

Director, Chief Medical & Scientific Officer

Masahiro Sakane

External

Existing

External Director, Chair of the Board Meeting

Yoshiaki Fujimori

External

Existing

External Director

Emiko Higashi

External

Existing

External Director

Michel Orsinger

External

Existing

External Director

Toshiyuki Shiga

External

Existing

External Director


2. New assignment of Audit and Supervisory Committee Directors effective June 28, 2018 

Name

Category

Current Role

Yasuhiko Yamanaka

Internal

Existing

Director, Full-time Audit & Supervisory Committee member

Shiro Kuniya

External

Existing

External Director, Chairperson of Audit & Supervisory Committee

Jean-Luc Butel

External

Existing

External Director, Audit & Supervisory Committee member

Koji Hatsukawa

External

Existing

External Director, Audit & Supervisory Committee member

 

3. New assignment of Non-Audit and Supervisory Committee Directors effective June 28, 2018;
  - Compensation committee : Toshiyuki Shiga (Chair), Yoshiaki Fujimori, Yasuhiko Yamanaka
  - Nomination committee      : Masahiro Sakane (Chair), Emiko Higashi,
                 Shiro Kuniya, Christophe Weber
 



Media Contact
Kazumi Kobayashi
Tel: +81-3-3278-2095
Email: kazumi.kobayashi@takeda.com